Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Approves New Nasal Spray for Migraines

The New York Times – Business:

Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.

Christina Jewett
Author: Christina Jewett

This post first appeared in The New York Times – Business. Read the original article.

Written by

Christina Jewett

in

Drugs (Pharmaceuticals), Food and Drug Administration, Lancet Neurology, The (Journal), Migraine Headaches, Nerves and Nervous System, Pfizer Inc
←RuPaul Shreds ‘Stunt Queen’ Politicians Pushing To Ban Drag Shows In Fiery Video
Michael Tilson Thomas Revels in the Present With the New York Phil→

More posts

  • Tony Robinson ‘Rewrites History’ With Debuting Radar Studios

  • Raids on suspected organised crime see 17 arrested

  • Officials are looking into possible new ransom note related to Nancy Guthrie disappearance

  • News organizations ask court to bar White House enforcement of access ban

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube